ebselen has been researched along with Cardiotoxicity in 1 studies
ebselen : A benzoselenazole that is 1,2-benzoselenazol-3-one carrying an additional phenyl substituent at position 2. Acts as a mimic of glutathione peroxidase.
Cardiotoxicity: Damage to the HEART or its function secondary to exposure to toxic substances such as drugs used in CHEMOTHERAPY; IMMUNOTHERAPY; or RADIATION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Arenobufagin is a naturally occurring bufadienolide showing promising antitumor activity accompanied however with apparent cardiac toxicity." | 7.88 | Hybrids of arenobufagin and benzoisoselenazol reducing the cardiotoxicity of arenobufagin. ( Chang, YQ; Chen, WM; Hou, W; Huang, ZX; Lin, H; Lin, J; Peng, QL; Sun, PH; Wang, LH; Xu, HG; Yao, Z; Zhang, DM, 2018) |
| "Arenobufagin is a naturally occurring bufadienolide showing promising antitumor activity accompanied however with apparent cardiac toxicity." | 3.88 | Hybrids of arenobufagin and benzoisoselenazol reducing the cardiotoxicity of arenobufagin. ( Chang, YQ; Chen, WM; Hou, W; Huang, ZX; Lin, H; Lin, J; Peng, QL; Sun, PH; Wang, LH; Xu, HG; Yao, Z; Zhang, DM, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hou, W | 1 |
| Huang, ZX | 1 |
| Xu, HG | 1 |
| Lin, J | 1 |
| Zhang, DM | 1 |
| Peng, QL | 1 |
| Lin, H | 1 |
| Chang, YQ | 1 |
| Wang, LH | 1 |
| Yao, Z | 1 |
| Sun, PH | 1 |
| Chen, WM | 1 |
1 other study available for ebselen and Cardiotoxicity
| Article | Year |
|---|---|
Hybrids of arenobufagin and benzoisoselenazol reducing the cardiotoxicity of arenobufagin.
Topics: Antineoplastic Agents; Bufanolides; Cardiotoxicity; Cell Line, Tumor; Drug Design; Free Radical Scav | 2018 |